Mono Pharmacare Limited (NSE:MONOPHARMA)

Mono Pharmacare Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	158	197	408	779	-	-
Market Cap Growth	-58.47%	-51.73%	-47.62%	-	-	-
Enterprise Value	714	735	894	1,134	-	-
Last Close Price	8.95	11.15	23.10	44.10	-	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	44.75	55.84	13.21	31.90	-	-
PS Ratio	0.10	0.12	0.24	0.64	-	-
PB Ratio	0.50	0.62	1.31	2.77	-	-
P/TBV Ratio	0.50	0.63	1.31	2.78	-	-
P/FCF Ratio	6.90	8.60	-	-	-	-
P/OCF Ratio	6.89	8.58	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.43	0.44	0.53	0.93	-	-
EV/EBITDA Ratio	17.80	18.33	11.46	17.72	-	-
EV/EBIT Ratio	18.33	18.87	11.65	18.05	-	-
EV/FCF Ratio	31.14	32.06	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	1.79	1.79	1.72	1.47	2.92	1.51
Debt / EBITDA Ratio	14.10	14.10	6.86	6.48	17.37	4.63
Debt / FCF Ratio	24.65	24.65	-	-	-	28.52
Net Debt / Equity Ratio	1.76	1.76	1.69	1.46	2.89	1.45
Net Debt / EBITDA Ratio	13.85	13.85	6.77	6.42	17.19	4.45
Net Debt / FCF Ratio	24.22	24.22	-11.67	-4.59	-0.98	27.43
Asset Turnover	1.43	1.43	1.76	1.70	0.86	2.90
Inventory Turnover	3.21	3.21	3.12	2.95	1.56	7.85
Quick Ratio	1.20	1.20	0.81	0.89	0.66	0.67
Current Ratio	1.92	1.92	2.07	2.24	1.82	1.64
Return on Equity (ROE)	1.12%	1.12%	10.46%	11.76%	10.52%	8.80%
Return on Assets (ROA)	2.10%	2.10%	5.02%	5.47%	3.65%	6.27%
Return on Invested Capital (ROIC)	2.74%	2.79%	6.97%	7.83%	5.06%	8.15%
Return on Capital Employed (ROCE)	6.60%	6.60%	13.40%	13.90%	7.70%	22.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.23%	1.79%	7.57%	3.14%	-	-
FCF Yield	14.49%	11.63%	-11.10%	-11.48%	-	-
Buyback Yield / Dilution	0.16%	0.16%	-15.09%	-171.01%	-15.18%	-

Data Source: S&P Global Market Intelligence Last updated: Jul 16, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error